Karışık Tip İdrar Kaçırma-Tedavi

Jha S, Jeppson PC, Dokmeci F, et al. Management of mixed urinary incontinence: IUGA committee opinion. Int Urogynecol J. 2024;35(2):291-301.

Nygaard IE. Evidence-based treatment for mixed urinary incontinence. JAMA. 2019;322(11):1049-51.

Hashim H, Abrams P. How should patients with an overactive bladder manipulate their fluid intake? BJU Int. 2008;102(1):62-6.

Subak LL, Wing R, West DS, et al. Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med. 2009;360(5):481-90.

Sar D, Khorshid L. The effects of pelvic floor muscle training on stress and mixed urinary incontinence and quality of life. J Wound Ostomy Continence Nurs. 2009;36(4):429-35.

Sung VW, Borello-France D, Newman DK, et al. Effect of behavioral and pelvic floor muscle therapy combined with surgery vs surgery alone on incontinence symptoms among women with mixed urinary incontinence: the ESTEEM randomized clinical trial. JAMA. 2019;322(11):1066-76.

Hagen S, Bugge C, Dean SG, et al. Basic versus biofeedback-mediated intensive pelvic floor muscle training for women with urinary incontinence: the OPAL RCT. Health Technol Assess (Winchester, England). 2020;24(70):1.

Cardozo L, Rovner E, Wagg A, Wein A, Abrams P. Incontinence. International Continence Society and International Consultation on Urological Disease. 2023.

Kaya S, Akbayrak T, Gursen C, Beksac S. Short-term effect of adding pelvic floor muscle training to bladder training for female urinary incontinence: a randomized controlled trial. Int Urogynecol J. 2015;26:285-93.

Stewart F, Berghmans B, Bø K, Glazener CM. Electrical stimulation with non-implanted devices for stress urinary incontinence in women. Cochrane Database Syst Rev. 2017;12(12):CD012390.

Liu B, Liu Y, Qin Z, et al. Electroacupuncture versus pelvic floor muscle training plus solifenacin for women with mixed urinary incontinence: a randomized noninferiority trial. Mayo Clin Proc. 2019;94(1):54-65.

Donnelly MJ, Powell-Morgan S, Olsen AL, Nygaard IE. Vaginal pessaries for the management of stress and mixed urinary incontinence. Int Urogynecol J. 2004;15:302-7.

Richter HE, Burgio KL, Brubaker L, et al. Continence pessary compared with behavioral therapy or combined therapy for stress incontinence: a randomized controlled trial. Obstet Gynecol. 2010;115(3):609-17.

Kobashi KC, Vasavada S, Bloschichak A, et al. Updates to surgical treatment of female stress urinary incontinence (SUI): AUA/SUFU guideline (2023). J Urol. 2023;209(6):1091-8.

Cameron AP, Chung DE, Dielubanza EJ, et al. The AUA/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder. J Urol. 2024;212(1):11-20.

Nambiar AK, Arlandis S, Bø K, et al. European association of urology guidelines on the diagnosis and management of female non-neurogenic lower urinary tract symptoms. Part 1: diagnostics, overactive bladder, stress urinary incontinence, and mixed urinary incontinence. Eur Urol. 2022;82(1):49-59.

Khullar V, Hill S, Laval K-U, Schiøtz HA, Jonas U, Versi E. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial. Urology. 2004;64(2):269-74.

Kreder K Jr, Brubaker L, Mainprize T. Tolterodine is equally effective in patients with mixed incontinence and those with urge incontinence alone. BJU Int. 2003;92(4):418-21.

Bent AE, Gousse AE, Hendrix SL, et al. Duloxetine compared with placebo for the treatment of women with mixed urinary incontinence. Neurourol Urodyn. 2008;27(3):212-21.

Bump RC, Norton PA, Zinner NR, Yalcin I, Group DUIS. Mixed urinary incontinence symptoms: urodynamic findings, incontinence severity, and treatment response. Obstet Gynecol. 2003;102(1):76-83.

Abdel-Fattah M, Cao G, Mostafa A. Long-term outcomes for transobturator tension-free vaginal tapes in women with urodynamic mixed urinary incontinence. Neurourol Urodyn. 2017;36(4):902-8.

Jain P, Jirschele K, Botros SM, Latthe PM. Effectiveness of midurethral slings in mixed urinary incontinence: a systematic review and meta-analysis. Int Urogynecol J. 2011;22(8):923-32.

Shirvan MK, Noughabi SAS, Rahimi HR. Tension-free vaginal tape plus intradetrusor BOTOX injection versus tension-free vaginal tape versus intradetrusor BOTOX injection in equal-weight mixed urinary incontinence: a prospective randomized study. J Gynecol Surg. 2013;29(5):235-40.

Ozkurkcugil C, Avci IE. Factors predicting treatment success in mixed urinary incontinence treated with midurethral sling. LUTS. 2023;15(2):50-6.

Peters KM, Carrico DJ, Perez-Marrero RA, et al. Randomized trial of percutaneous tibial nerve stimulation versus sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol. 2010;183(4):1438-43.

Herschorn S, Kohan A, Aliotta P, et al. The efficacy and safety of onabotulinumtoxinA or solifenacin compared with placebo in solifenacin naïve patients with refractory overactive bladder: results from a multicenter, randomized, double-blind phase 3b trial. J Urol. 2017;198(1):167-75.

Siegel S, Noblett K, Mangel J, et al. Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6 months in subjects with mild symptoms of overactive bladder. Neurourol Urodyn. 2015;34(3):224-30.

Amundsen CL, Richter HE, Menefee SA, et al. OnabotulinumtoxinA vs sacral neuromodulation on refractory urgency urinary incontinence in women: a randomized clinical trial. JAMA. 2016;316(13):1366-74.

Lee JS, Dwyer P, Rosamilia A, Lim Y, Polyakov A, Stav K. Persistence of urgency and urge urinary incontinence in women with mixed urinary symptoms after midurethral slings: a multivariate analysis. BJOG. 2011;118(7):798-805.

Paick JS, Ku JH, Kim SW, Oh SJ, Son H, Shin JW. Tension-free vaginal tape procedure for the treatment of mixed urinary incontinence: significance of maximal urethral closure pressure. J Urol. 2004;172(3):1001-5.

Cohen BL, Caruso DJ, Kanagarajah P, Gousse AE. Predictors of response to intradetrusor botulinum toxin-A injections in patients with idiopathic overactive bladder. Adv Urol. 2009;2009(1):328364.

Nobrega RP, Solomon E, Jenks J, Greenwell T, Ockrim J. Predicting a successful outcome in sacral neuromodulation testing: are urodynamic parameters prognostic? Neurourol Urodyn. 2018;37(3):1007-10.

Jha S, Jeppson PC, Dokmeci F, et al. Management of mixed urinary incontinence: IUGA committee opinion. Int Urogynecol J. 2024;35(2):291-301.

Nygaard IE. Evidence-based treatment for mixed urinary incontinence. JAMA. 2019;322(11):1049-51.

Hashim H, Abrams P. How should patients with an overactive bladder manipulate their fluid intake? BJU Int. 2008;102(1):62-6.

Subak LL, Wing R, West DS, et al. Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med. 2009;360(5):481-90.

Sar D, Khorshid L. The effects of pelvic floor muscle training on stress and mixed urinary incontinence and quality of life. J Wound Ostomy Continence Nurs. 2009;36(4):429-35.

Sung VW, Borello-France D, Newman DK, et al. Effect of behavioral and pelvic floor muscle therapy combined with surgery vs surgery alone on incontinence symptoms among women with mixed urinary incontinence: the ESTEEM randomized clinical trial. JAMA. 2019;322(11):1066-76.

Hagen S, Bugge C, Dean SG, et al. Basic versus biofeedback-mediated intensive pelvic floor muscle training for women with urinary incontinence: the OPAL RCT. Health Technol Assess (Winchester, England). 2020;24(70):1.

Cardozo L, Rovner E, Wagg A, Wein A, Abrams P. Incontinence. International Continence Society and International Consultation on Urological Disease. 2023.

Kaya S, Akbayrak T, Gursen C, Beksac S. Short-term effect of adding pelvic floor muscle training to bladder training for female urinary incontinence: a randomized controlled trial. Int Urogynecol J. 2015;26:285-93.

Stewart F, Berghmans B, Bø K, Glazener CM. Electrical stimulation with non-implanted devices for stress urinary incontinence in women. Cochrane Database Syst Rev. 2017;12(12):CD012390.

Liu B, Liu Y, Qin Z, et al. Electroacupuncture versus pelvic floor muscle training plus solifenacin for women with mixed urinary incontinence: a randomized noninferiority trial. Mayo Clin Proc. 2019;94(1):54-65.

Donnelly MJ, Powell-Morgan S, Olsen AL, Nygaard IE. Vaginal pessaries for the management of stress and mixed urinary incontinence. Int Urogynecol J. 2004;15:302-7.

Richter HE, Burgio KL, Brubaker L, et al. Continence pessary compared with behavioral therapy or combined therapy for stress incontinence: a randomized controlled trial. Obstet Gynecol. 2010;115(3):609-17.

Kobashi KC, Vasavada S, Bloschichak A, et al. Updates to surgical treatment of female stress urinary incontinence (SUI): AUA/SUFU guideline (2023). J Urol. 2023;209(6):1091-8.

Cameron AP, Chung DE, Dielubanza EJ, et al. The AUA/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder. J Urol. 2024;212(1):11-20.

Nambiar AK, Arlandis S, Bø K, et al. European association of urology guidelines on the diagnosis and management of female non-neurogenic lower urinary tract symptoms. Part 1: diagnostics, overactive bladder, stress urinary incontinence, and mixed urinary incontinence. Eur Urol. 2022;82(1):49-59.

Khullar V, Hill S, Laval K-U, Schiøtz HA, Jonas U, Versi E. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial. Urology. 2004;64(2):269-74.

Kreder K Jr, Brubaker L, Mainprize T. Tolterodine is equally effective in patients with mixed incontinence and those with urge incontinence alone. BJU Int. 2003;92(4):418-21.

Bent AE, Gousse AE, Hendrix SL, et al. Duloxetine compared with placebo for the treatment of women with mixed urinary incontinence. Neurourol Urodyn. 2008;27(3):212-21.

Bump RC, Norton PA, Zinner NR, Yalcin I, Group DUIS. Mixed urinary incontinence symptoms: urodynamic findings, incontinence severity, and treatment response. Obstet Gynecol. 2003;102(1):76-83.

Abdel-Fattah M, Cao G, Mostafa A. Long-term outcomes for transobturator tension-free vaginal tapes in women with urodynamic mixed urinary incontinence. Neurourol Urodyn. 2017;36(4):902-8.

Jain P, Jirschele K, Botros SM, Latthe PM. Effectiveness of midurethral slings in mixed urinary incontinence: a systematic review and meta-analysis. Int Urogynecol J. 2011;22(8):923-32.

Shirvan MK, Noughabi SAS, Rahimi HR. Tension-free vaginal tape plus intradetrusor BOTOX injection versus tension-free vaginal tape versus intradetrusor BOTOX injection in equal-weight mixed urinary incontinence: a prospective randomized study. J Gynecol Surg. 2013;29(5):235-40.

Ozkurkcugil C, Avci IE. Factors predicting treatment success in mixed urinary incontinence treated with midurethral sling. LUTS. 2023;15(2):50-6.

Peters KM, Carrico DJ, Perez-Marrero RA, et al. Randomized trial of percutaneous tibial nerve stimulation versus sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol. 2010;183(4):1438-43.

Herschorn S, Kohan A, Aliotta P, et al. The efficacy and safety of onabotulinumtoxinA or solifenacin compared with placebo in solifenacin naïve patients with refractory overactive bladder: results from a multicenter, randomized, double-blind phase 3b trial. J Urol. 2017;198(1):167-75.

Siegel S, Noblett K, Mangel J, et al. Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6 months in subjects with mild symptoms of overactive bladder. Neurourol Urodyn. 2015;34(3):224-30.

Amundsen CL, Richter HE, Menefee SA, et al. OnabotulinumtoxinA vs sacral neuromodulation on refractory urgency urinary incontinence in women: a randomized clinical trial. JAMA. 2016;316(13):1366-74.

Lee JS, Dwyer P, Rosamilia A, Lim Y, Polyakov A, Stav K. Persistence of urgency and urge urinary incontinence in women with mixed urinary symptoms after midurethral slings: a multivariate analysis. BJOG. 2011;118(7):798-805.

Paick JS, Ku JH, Kim SW, Oh SJ, Son H, Shin JW. Tension-free vaginal tape procedure for the treatment of mixed urinary incontinence: significance of maximal urethral closure pressure. J Urol. 2004;172(3):1001-5.

Cohen BL, Caruso DJ, Kanagarajah P, Gousse AE. Predictors of response to intradetrusor botulinum toxin-A injections in patients with idiopathic overactive bladder. Adv Urol. 2009;2009(1):328364.

Nobrega RP, Solomon E, Jenks J, Greenwell T, Ockrim J. Predicting a successful outcome in sacral neuromodulation testing: are urodynamic parameters prognostic? Neurourol Urodyn. 2018;37(3):1007-10.